James M. Frates, CFO: Amylyx Pharmaceuticals AMLX Sell · Filed 24/01/11

Trade details

Type: Insider sale
Amount: $44,352.28
Shares · price: 2,716 sh · $16.33 a share
Held after: 112,035 sh
Stock: Amylyx Pharmaceuticals AMLX
Person: James M. FratesCFO
Trade date: 24/01/09
Filed: 24/01/11
Days to filing: 2 days

Sold 2.4% of holdings

Share of holding sold: 2.4%

Amylyx Pharmaceuticals trades, last 26 weeks

What else happened in Amylyx Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/12/10~24/02/08

James M. Frates's recent trades

James M. FratesCFO
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$349.8K
10,810 sh
$349.8K
Filed 09/11
Traded 09/10
James M. FratesCFO
SellAmylyx Pharmaceuticals
Sell
Amylyx Pharmaceuticals
AMLX
$114.8K
7,909 sh
$114.8K
Filed 03/04
Traded 03/02
James M. FratesCFO
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$114.9K
7,909 sh
$114.9K
Filed 03/02
Traded 03/02
James M. FratesCFO
SellAmylyx Pharmaceuticals
Sell
Amylyx Pharmaceuticals
AMLX
$52.1K
3,557 sh
$52.1K
Filed 02/04
Traded 02/02
James M. FratesCFO
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$52.1K
3,557 sh
$52.1K
Filed 02/02
Traded 02/02